These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25518715)

  • 21. Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection.
    Wang Y; Si L; Luo Y; Guo X; Zhou J; Fang D; Yan H; Zeng G; Jiang L
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9685-98. PubMed ID: 26219500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests.
    Johnson BW; Kosoy O; Hunsperger E; Beltran M; Delorey M; Guirakhoo F; Monath T
    Clin Vaccine Immunol; 2009 Jul; 16(7):1052-9. PubMed ID: 19458204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced immune responses against Japanese encephalitis virus using recombinant adenoviruses coexpressing Japanese encephalitis virus envelope and porcine interleukin-6 proteins in mice.
    Liu H; Wu R; Liu K; Yuan L; Huang X; Wen Y; Ma X; Yan Q; Zhao Q; Wen X; Cao S
    Virus Res; 2016 Aug; 222():34-40. PubMed ID: 27235810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival of mice immunized with monoclonal antibodies against glycoprotein E of Japanese encephalitis virus before or after infection with Japanese encephalitis, West Nile, and Dengue viruses.
    Gupta AK; Lad VJ; Koshy AA
    Acta Virol; 2008; 52(4):219-24. PubMed ID: 19143477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oleic acid Enhances Dengue Virus But Not Dengue Virus-Like Particle Production from Mammalian Cells.
    Ramphan S; Suksathan S; Wikan N; Ounjai P; Boonthaworn K; Rimthong P; Kanjanapruthipong T; Worawichawong S; Jongkaewwattana A; Wongsiriroj N; Smith DR
    Mol Biotechnol; 2017 Oct; 59(9-10):385-393. PubMed ID: 28791613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the protective ability of plasma from Japanese individuals against mosquito-borne viral infections.
    Shinohara N; Owada T; Matsumoto C; Uchida S; Nagai T; Satake M; Tadokoro K
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):393-401. PubMed ID: 29294131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus.
    Yang J; Yang H; Li Z; Lin H; Zhao Y; Wang W; Tan S; Zeng X; Li Y
    Protein Cell; 2017 Mar; 8(3):225-229. PubMed ID: 28124229
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular basis for adaptation of a chimeric dengue type-4/Japanese encephalitis virus to Vero cells.
    Tang WF; Eshita Y; Tadano M; Morita K; Makino Y
    Microbiol Immunol; 2005; 49(3):285-94. PubMed ID: 15782002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo characterization of chimeric duck Tembusu virus based on Japanese encephalitis live vaccine strain SA14-14-2.
    Wang HJ; Liu L; Li XF; Ye Q; Deng YQ; Qin ED; Qin CF
    J Gen Virol; 2016 Jul; 97(7):1551-1556. PubMed ID: 27100268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of single-round infectious chimeric flaviviruses with DNA-based Japanese encephalitis virus replicon.
    Suzuki R; Ishikawa T; Konishi E; Matsuda M; Watashi K; Aizaki H; Takasaki T; Wakita T
    J Gen Virol; 2014 Jan; 95(Pt 1):60-65. PubMed ID: 24096319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-positivity of anti-dengue virus and anti-Japanese encephalitis virus IgM in endemic area: co-infection or cross reactivity?
    Singh KP; Mishra G; Jain P; Pandey N; Nagar R; Gupta S; Prakash S; Prakash O; Khan DN; Shrivastav S; Singh DD; Jain A
    Asian Pac J Trop Med; 2014 Feb; 7(2):124-9. PubMed ID: 24461525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to improve the immunogenicity of prM+E dengue virus type-2 DNA vaccine.
    Ketloy C; Keelapang P; Prompetchara E; Suphatrakul A; Puttikhunt C; Kasinrerk W; Konishi E; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2017 Mar; 35(1):11-19. PubMed ID: 27001660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.
    Chang GJ; Hunt AR; Holmes DA; Springfield T; Chiueh TS; Roehrig JT; Gubler DJ
    Virology; 2003 Feb; 306(1):170-80. PubMed ID: 12620809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection.
    Wang J; Li X; Gu J; Fan Y; Zhao P; Cao R; Chen P
    Infect Genet Evol; 2015 Dec; 36():116-125. PubMed ID: 26384477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2.
    Li SH; Li XF; Zhao H; Deng YQ; Yu XD; Zhu SY; Jiang T; Ye Q; Qin ED; Qin CF
    Virol J; 2013 Feb; 10():64. PubMed ID: 23442449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Identification and construction of replicon vectors of Japanese encephalitis virus (strain SA14-14-2)].
    Wei Y; Li C; Lu P; Yu JS; Li JD; Liu QZ; Zhang QF; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):418-20. PubMed ID: 20718343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonstructural protein 1 antibody-based epitope-blocking enzyme-linked immunosorbent assay to differentiate Japanese encephalitis virus from dengue virus infections in humans.
    Konishi E; Konishi M
    Jpn J Infect Dis; 2011; 64(4):284-91. PubMed ID: 21788702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses.
    Keelapang P; Sriburi R; Supasa S; Panyadee N; Songjaeng A; Jairungsri A; Puttikhunt C; Kasinrerk W; Malasit P; Sittisombut N
    J Virol; 2004 Mar; 78(5):2367-81. PubMed ID: 14963133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.